Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor (Q48156562)

9 February 2018

title

Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor (English)

1 reference

9 February 2018

0 references

Hjorth S

1

1 reference

9 February 2018

Auerbach SB

series ordinal

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

published in

Brain Research

1 reference

9 February 2018

volume

835

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

224-228

1 reference

9 February 2018

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Effects of antidepressant agents on the synthesis of brain monoamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Raphe neurons: effect of tricyclic antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901585-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(99)01585-1

1 reference

9 February 2018

1 reference

9 February 2018